These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13065126)

  • 1. [Visualization of tissue immune reactions].
    JANCSO N; JANCSO-GABOR A
    Acta Physiol Acad Sci Hung; 1952; 3(3-4):555-62. PubMed ID: 13065126
    [No Abstract]   [Full Text] [Related]  

  • 2. An attachment of protamines to cerebral tissues, studied in relation to gangliosides, suramin and tissue excitability.
    THOMSON CG; McILWAIN H
    Biochem J; 1961 May; 79(2):342-7. PubMed ID: 13776646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cellular partition and storage mechanism of Bayer 205 (Germanin) in the tissues].
    JANCSO N; JANCSO-GABOR A
    Acta Physiol Acad Sci Hung; 1952; 3(3-4):537-54. PubMed ID: 13065125
    [No Abstract]   [Full Text] [Related]  

  • 4. Suramin inhibits EV71 infection.
    Wang Y; Qing J; Sun Y; Rao Z
    Antiviral Res; 2014 Mar; 103():1-6. PubMed ID: 24374150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of anti-allergic activity of gossypin and suramin in mast cell-mediated allergy model.
    Ganapaty S; Chandrashekhar VM; Narsu ML
    Indian J Biochem Biophys; 2010 Apr; 47(2):90-5. PubMed ID: 20521621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of suramin on the activities of degradative enzymes of sphingolipids in rats.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):87-97. PubMed ID: 7291729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.
    Monteiro RQ; Campana PT; Melo PA; Bianconi ML
    Int J Biochem Cell Biol; 2004 Oct; 36(10):2077-85. PubMed ID: 15203120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
    Balcar VJ; Dias LS; Li Y; Bennett MR
    Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond immune escape: a variant surface glycoprotein causes suramin resistance in Trypanosoma brucei.
    Wiedemar N; Graf FE; Zwyer M; Ndomba E; Kunz Renggli C; Cal M; Schmidt RS; Wenzler T; Mäser P
    Mol Microbiol; 2018 Jan; 107(1):57-67. PubMed ID: 28963732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A.
    Ren P; Zheng Y; Wang W; Hong L; Delpeyroux F; Arenzana-Seisdedos F; Altmeyer R
    Sci Rep; 2017 Feb; 7():42902. PubMed ID: 28218309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the suramin-binding sites of human neutrophil elastase: investigation by fluorescence resonance energy transfer and molecular modeling.
    Mély Y; Cadène M; Sylte I; Bieth JG
    Biochemistry; 1997 Dec; 36(50):15624-31. PubMed ID: 9398290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.
    Nautiyal A; Patil KN; Muniyappa K
    J Antimicrob Chemother; 2014 Jul; 69(7):1834-43. PubMed ID: 24722837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of granulocyte-macrophage colony-stimulating factor (GM-CSF) activity by suramin and suramin analogues is correlated to interaction with the GM-CSF nucleotide-binding site.
    Doukas M; Chavan A; Gass C; Nickel P; Boone T; Haley B
    Cancer Res; 1995 Nov; 55(22):5161-3. PubMed ID: 7585565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation.
    Regmi A; Fuson T; Yang X; Kays J; Moxham C; Zartler E; Chandrashekhar S; Galvin RJ
    Bone; 2005 Feb; 36(2):284-91. PubMed ID: 15780954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation.
    LaRocca RV; Cooper MR; Uhrich M; Danesi R; Walther MM; Linehan WM; Myers CE
    Urol Clin North Am; 1991 Feb; 18(1):123-9. PubMed ID: 1992566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin is a novel activator of PP5 and biphasically modulates S100-activated PP5 activity.
    Yamaguchi F; Yamamura S; Shimamoto S; Tokumitsu H; Tokuda M; Kobayashi R
    Appl Biochem Biotechnol; 2014 Jan; 172(1):237-47. PubMed ID: 24068474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
    Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
    Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the mechanism of the antimitogenic activity of suramin.
    Kathir KM; Kumar TK; Yu C
    Biochemistry; 2006 Jan; 45(3):899-906. PubMed ID: 16411766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity.
    Yegutkin GG; Jankowski J; Jalkanen S; Günthner T; Zidek W; Jankowski V
    Biosci Rep; 2008 Aug; 28(4):189-94. PubMed ID: 18576946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation of the trypanocidal pharmaceutical suramin in its free and bound forms: transferred nuclear overhauser studies.
    Polenova T; Iwashita T; Palmer AG; McDermott AE
    Biochemistry; 1997 Nov; 36(46):14202-17. PubMed ID: 9369494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.